NON-MEDICAL REVERSE SWITCH BETWEEN THE ORIGINATOR INFLIXIMAB AND ITS BIOSIMILAR IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: CLINICAL OUTCOMES AND THERAPEUTIC DRUG MONITORING

GASTROENTEROLOGY(2019)

引用 1|浏览7
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要